drugset / Trial / NCT03715465

The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder

NCT03715465

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will test whether measuring the circadian clock during treatment of delayed sleep-wake phase disorder results in greater improvements in sleep compared to estimating the circadian clock.

Timeline

Start
2019-02-15
Primary completion
2021-11-05
Completion
2021-11-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 0.5 mg